How is the Fecal Microbiota Transplantation (FMT) Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the fecal microbiota transplantation (fmt) market size evolved in recent years?
The fecal microbiota transplantation (FMT) market has exhibited strong growth and is expected to expand from $0.85 billion in 2024 to $0.91 billion in 2025, at a CAGR of 7.2%. Growth factors include increasing awareness of the gut microbiome, expanding therapeutic applications, the rise of personalized medicine, adoption in gastroenterology practices, a growing number of clinical trials, and increased funding and investment.
What are the predictions for the fecal microbiota transplantation (fmt) market size in the coming years?
The fecal microbiota transplantation (FMT) market is anticipated to grow significantly, reaching $1.19 billion by 2029 at a CAGR of 6.9%. Growth factors include the rising incidence of Clostridium difficile infections (CDI), increasing cases of inflammatory bowel diseases, growing R&D efforts, an aging population, and expanding healthcare infrastructure. Key trends include standardized donor screening protocols, advancements in microbiome analysis, improved stool processing methods, novel delivery techniques, and the development of synthetic microbiota-based products.
Get your fecal microbiota transplantation (fmt) market report here!
What key factors are fueling the growth of the fecal microbiota transplantation (fmt) market?
The rising prevalence of gastrointestinal disorders, linked to stress, sedentary lifestyles, and processed food consumption, is fueling the fecal microbiota transplantation (FMT) market. This procedure restores healthy gut bacteria, particularly for treating recurrent Clostridioides difficile infections. According to Crohn’s and Colitis Canada, the number of people with IBD in Canada increased from 322,600 in 2023 (0.8% of the population) and is projected to reach 470,000 by 2035 (1.1% of the population). In 2023 alone, 11,000 new cases were diagnosed (one every 48 minutes), a figure expected to rise to 14,000 by 2035 (one every 38 minutes). Therefore, the growing prevalence of gastrointestinal disorders is driving the FMT market.
How is the global fecal microbiota transplantation (fmt) market divided into key segments?
The fecal microbiota transplantation (FMT) market covered in this report is segmented –
1) By Type: Fermentation, Fresh, Cryopreservation
2) By Donor Type: Stool-Derived, Fecal-Derived, Whole-Microbiome Derived
3) By Indication: Clostridioides Difficile Infection, Inflammatory Bowel Disease, Metabolic Syndrome, Other Indications
4) By Administration Route: Oral, Rectal, Nasogastric, Colon Capsule
5) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Fermentation: Fermented FMT Products, Fermented Capsules, Fermented Liquids, In-House Fermentation Techniques
2) By Fresh: Fresh Stool Samples, Fresh FMT Capsules, Fresh FMT Solutions for In-Hospital Use, Freshly Prepared FMT for Outpatient Use
3) By Cryopreservation: Cryopreserved Stool Samples, Cryopreserved FMT Capsules, Cryopreserved Liquid FMT, Long-Term Storage Solutions for Cryopreserved FMT
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19430&type=smp
Who are the key firms paving the way for growth in the fecal microbiota transplantation (fmt) market?
Major companies operating in the fecal microbiota transplantation (FMT) market are Ferring Pharmaceuticals, Johns Hopkins Medicine, Seres Therapeutics, Taconic Biosciences, Enterome, Rebiotix Inc., Finch Therapeutics Group Inc., Locus Biosciences, Yeda Research and Development Co. Ltd., Microbiotica Limited, CosmosID Inc., AOBiome, Synthetic Biologics Inc., Osel Inc., OpenBiome, Asia Microbiota Bank, Taymount Clinic, MicroBiome Therapeutics LLC, MaaT Pharma SA, Kallyope
Which trends are expected to transform the fecal microbiota transplantation (fmt) market?
Leading corporations in the fecal microbiota transplantation (FMT) sector are focusing on creating cutting-edge solutions, such as live biotherapeutics based on microbiota, to improve treatment efficiency for gastrointestinal conditions. Live biotherapeutics based on microbiota pertains to live microorganisms utilized as therapy agents to mend or alter the gut microbiome to cure several diseases. For instance, Ferring Pharmaceuticals, a biopharmaceutical firm based in Switzerland, got approval from the US Food and Drug Administration (FDA) in November 2022 for REBYOTA (fecal microbiota, live-jslm). This revolutionary first-in-its-class live biotherapeutic based on microbiota is intended for the prevention of repeat Clostridioides difficile infection (CDI) in people aged 18 and above after antibiotic treatment for chronic CDI. REBYOTA is indicated for avoiding the reoccurrence of Clostridioides difficile (C. difficile) infection in individuals aged 18 and over following antibiotic treatment for recurrent CDI.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19430
What regions are contributing significantly to the growth of the fecal microbiota transplantation (fmt) market?
North America was the largest region in the fecal microbiota transplantation (FMT) market in 2024. The regions covered in the fecal microbiota transplantation (FMT) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Heart Transplant Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report
Kidney Transplant Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/kidney-transplant-global-market-report
Organ Transplant Immunosuppressant Drugs Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
